Style | Citing Format |
---|---|
MLA | Sabeghi D, et al.. "Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations." Acta Neurologica Belgica, vol. 124, no. 4, 2024, pp. 1363-1370. |
APA | Sabeghi D, Inanloorahatloo K, Mirzadeh HS, Khani M, Shamshiri H, Taghavi T, Alavi A, Boostani R, Tonekaboni SH, Akhondian J, Ebrahimi M, Salehi N, Nafissi S, Elahi E (2024). Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations. Acta Neurologica Belgica, 124(4), 1363-1370. |
Chicago | Sabeghi D, Inanloorahatloo K, Mirzadeh HS, Khani M, Shamshiri H, Taghavi T, Alavi A, et al.. "Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations." Acta Neurologica Belgica 124, no. 4 (2024): 1363-1370. |
Harvard | Sabeghi D et al. (2024) 'Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations', Acta Neurologica Belgica, 124(4), pp. 1363-1370. |
Vancouver | Sabeghi D, Inanloorahatloo K, Mirzadeh HS, Khani M, Shamshiri H, Taghavi T, et al.. Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations. Acta Neurologica Belgica. 2024;124(4):1363-1370. |
BibTex | @article{ author = {Sabeghi D and Inanloorahatloo K and Mirzadeh HS and Khani M and Shamshiri H and Taghavi T and Alavi A and Boostani R and Tonekaboni SH and Akhondian J and Ebrahimi M and Salehi N and Nafissi S and Elahi E}, title = {Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations}, journal = {Acta Neurologica Belgica}, volume = {124}, number = {4}, pages = {1363-1370}, year = {2024} } |
RIS | TY - JOUR AU - Sabeghi D AU - Inanloorahatloo K AU - Mirzadeh HS AU - Khani M AU - Shamshiri H AU - Taghavi T AU - Alavi A AU - Boostani R AU - Tonekaboni SH AU - Akhondian J AU - Ebrahimi M AU - Salehi N AU - Nafissi S AU - Elahi E TI - Atypical Presentations in an Rtd Patient and Report of Novel Slc52a3 and Slc52a2 Mutations JO - Acta Neurologica Belgica VL - 124 IS - 4 SP - 1363 EP - 1370 PY - 2024 ER - |